Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Swiss Funds Association welcomes cooperation with ESMA and EU on alternative investment funds

Monday, December 03, 2012
Opalesque Industry Update – The European Securities and Markets Authority (ESMA) has approved the cooperation arrangements with the Swiss Financial Market Supervisory Authority FINMA for the supervision of AIFs. The Swiss Funds Association SFA is pleased that this important agreement could be reached before the end of the year.

Under the regulations on third countries in the Alternative Investment Fund Managers Directive (AIFMD), the conclusion of cooperation agreements on supervision is one of the prerequisites for Swiss asset managers of AIFs to gain EU market access.

ESMA negotiated the corresponding agreements with FINMA on behalf of all 27 EU national competent authorities for securities markets regulation.

“This agreement with ESMA marks an initial milestone en route to ensuring market access for Swiss asset managers. We are pleased that the agreement between the supervisory authorities could be reached so quickly, and that FINMA has been able to implement this before the end of the year,” said SFA CEO Dr. Matthäus Den Otter.

Press release

www.sfa.ch

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its